Stoke Therapeutics, Inc. · NASDAQ:STOK

FMR LLC reported a 12.50% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 5, 2025

FMR LLC reported a 12.50% stake in Stoke Therapeutics, Inc., 6,865,057 shares, as a passive investor on Sep 30, 2025. Filed Nov 5, 2025 (Schedule 13G/A).

Stake
12.50%
Shares
6,865,057
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
FMR LLC12.50%6,865,057
Abigail P. Johnson12.50%6,865,057

Source

View original at SEC

Related